<?xml version="1.0" encoding="UTF-8"?>
<p id="p0320">A possible strategy to limit viral infections is the restriction of the trafficking of furin to 
 <italic>trans-</italic>Golgi network or to early Golgi compartments, where the pro-protein convertase remains inactive 
 <xref rid="b0065" ref-type="bibr">[13]</xref>. In this regard, streptamine derivatives may be particularly promising for targeted therapy, since the positioning of the guanidyl substituents leads to a localisation of the inhibitor into distinct subcellular compartments, such as endosomes or the Golgi complex 
 <xref rid="b0510" ref-type="bibr">[102]</xref>.
</p>
